Literature DB >> 8434993

Psychosocial adjustment of adult survivors of a paediatric dialysis and transplant programme.

J M Reynolds1, M J Morton, M E Garralda, R J Postlethwaite, D Goh.   

Abstract

The social adjustment of 45 young adult renal patients who commenced treatment for end stage renal disease (ESRD) as children and of 48 age and sex matched controls were compared. Renal patients were less socially mature than controls. More lived with their parents, fewer had an intimate relationship outside the family, they had fewer school qualifications, and there was more unemployment among them. The majority, however, were in employment and the level of subjective stress and support derived from most of these areas was comparable in renal patients and in controls. Having a close relationship with a member of the opposite sex was the only domain in which renal patients reported more stress than controls. Early start of illness and current health problems were associated with poorer social outcome. A lifelong history of ESRD leads to suboptimal or delayed social functioning on conventional indicators. However this does not lead to increased overall distress in the patients about their social circumstances and quality of life does not appear to be substantially impaired.

Entities:  

Mesh:

Year:  1993        PMID: 8434993      PMCID: PMC1029194          DOI: 10.1136/adc.68.1.104

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  Combined report on regular dialysis and transplantation of children in Europe, 1990.

Authors:  G Rizzoni; J H Ehrich; F P Brunner; W Geerlings; W Fassbinder; P Landais; N Mallick; R Margreiter; A E Raine; N H Selwood
Journal:  Nephrol Dial Transplant       Date:  1991       Impact factor: 5.992

2.  The use of the social stress and support interview in families with deviant children: methodological issues.

Authors:  D Bailey; M E Garralda
Journal:  Soc Psychiatry       Date:  1987

3.  The second individuation process in handicapped adolescents.

Authors:  S Shulman; C I Rubinroit
Journal:  J Adolesc       Date:  1987-12

4.  Adolescents' adjustment to chronic hemodialysis.

Authors:  A K De-Nour
Journal:  Am J Psychiatry       Date:  1979-04       Impact factor: 18.112

5.  Psychiatric adjustment in children with chronic renal failure.

Authors:  M E Garralda; R A Jameson; J M Reynolds; R J Postlethwaite
Journal:  J Child Psychol Psychiatry       Date:  1988-01       Impact factor: 8.982

6.  Quality of life for long-term survivors of end-stage renal disease.

Authors:  E O Poznanski; E Miller; C Salguero; R C Kelsh
Journal:  JAMA       Date:  1978-06-02       Impact factor: 56.272

7.  End stage renal failure: 14 years' experience of dialysis and renal transplantation.

Authors:  G Offner; C Aschendorff; P F Hoyer; H P Krohn; J H Ehrich; R Pichlmayr; J Brodehl
Journal:  Arch Dis Child       Date:  1988-02       Impact factor: 3.791

8.  How parents and families cope with chronic renal failure.

Authors:  J M Reynolds; M E Garralda; R A Jameson; R J Postlethwaite
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

9.  Medical compliance and coping with cystic fibrosis.

Authors:  D R Czajkowski; G P Koocher
Journal:  J Child Psychol Psychiatry       Date:  1987-03       Impact factor: 8.982

10.  Long term outcome of treatment of end stage renal failure.

Authors:  P Henning; L Tomlinson; S P Rigden; G B Haycock; C Chantler
Journal:  Arch Dis Child       Date:  1988-01       Impact factor: 3.791

View more
  11 in total

Review 1.  Surviving chronic physical illness: psychosocial outcome in adult life.

Authors:  J Gledhill; L Rangel; E Garralda
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

Review 2.  Lessons from psychosocial studies of chronic renal failure.

Authors:  R J Postlethwaite; M E Garralda; D M Eminson; J Reynolds
Journal:  Arch Dis Child       Date:  1996-11       Impact factor: 3.791

3.  Health-related quality of life functioning over a 2-year period in children with end-stage renal disease.

Authors:  Shari K Neul; Charles G Minard; Helen Currier; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2012-09-28       Impact factor: 3.714

4.  Trends in treatment and outcomes of survival of adolescents initiating end-stage renal disease care in the United States of America.

Authors:  Maria E Ferris; Debbie S Gipson; Paul L Kimmel; Paul W Eggers
Journal:  Pediatr Nephrol       Date:  2006-05-06       Impact factor: 3.714

Review 5.  Problems and pitfalls of transition from paediatric to adult renal care.

Authors:  Alan R Watson
Journal:  Pediatr Nephrol       Date:  2004-12-31       Impact factor: 3.714

6.  Pediatric end stage renal disease health-related quality of life differs by modality: a PedsQL ESRD analysis.

Authors:  Stuart L Goldstein; Nicole M Rosburg; Bradley A Warady; Mouin Seikaly; Ruth McDonald; Christine Limbers; James W Varni
Journal:  Pediatr Nephrol       Date:  2009-05-07       Impact factor: 3.714

Review 7.  Sociodemographic, Psychologic Health, and Lifestyle Outcomes in Young Adults on Renal Replacement Therapy.

Authors:  Alexander J Hamilton; Rhian L Clissold; Carol D Inward; Fergus J Caskey; Yoav Ben-Shlomo
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-19       Impact factor: 8.237

Review 8.  Cognitive deficits related to major organ failure: the potential role of neuropsychological testing.

Authors:  M E Farmer
Journal:  Neuropsychol Rev       Date:  1994-06       Impact factor: 7.444

9.  Short stature and chronic renal failure: what concerns children and parents?

Authors:  J M Reynolds; A J Wood; D M Eminson; R J Postlethwaite
Journal:  Arch Dis Child       Date:  1995-07       Impact factor: 3.791

Review 10.  Young adults' perspectives on living with kidney failure: a systematic review and thematic synthesis of qualitative studies.

Authors:  Phillippa K Bailey; Alexander J Hamilton; Rhian L Clissold; Carol D Inward; Fergus J Caskey; Yoav Ben-Shlomo; Amanda Owen-Smith
Journal:  BMJ Open       Date:  2018-01-10       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.